Literature DB >> 20096531

Simultaneous analysis of bambuterol and its active metabolite terbutaline enantiomers in rat plasma by chiral liquid chromatography-tandem mass spectrometry.

Wenxia Luo1, Lin Zhu, Jifeng Deng, Aiming Liu, Bin Guo, Wen Tan, Renke Dai.   

Abstract

A chiral liquid chromatography-tandem mass spectrometry (LC-MS/MS) simultaneous stereoselective analysis of bambuterol and its active metabolite terbutaline enantiomers in Wistar rat plasma has been developed and validated. All analytes and the internal standard were extracted from rat plasma samples by liquid-liquid extraction, separated on macrocyclic glycopeptide teicoplanin column with mobile phase constituted of 20mM ammonium acetate solution-methanol (10:90, v/v) at a flow-rate of 0.4 mL/min. Detection was performed on an API 3000 tandem mass spectrometer with positive electrospray ionization in multiple reaction monitoring mode. The calibration curves in the range 1-800 ng/mL were linear and the accuracy for each analyte was within 8.0%. The intra- and inter-day precision as determined from quality control samples was less than 10.1%. The validated assay was successfully used to determine the enantiomers of bambuterol and terbutaline in rat plasma samples in the pharmacokinetic studies of rac-bambuterol. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20096531     DOI: 10.1016/j.jpba.2009.12.020

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  Comparative pharmacokinetics and bile transformation of R-enantiomer and racemic bambuterol after single-dose intravenous, oral administration in rats and beagle dogs.

Authors:  Su Guan; Chun-Yun Hu; Meng-Ying He; Ying-Ying Yang; Yu-Xin Tang; Jie-di Chen; Li-Jie Huang; Wen Tan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-10-04       Impact factor: 2.441

2.  Synchronous fluorescence as a green and selective tool for simultaneous determination of bambuterol and its main degradation product, terbutaline.

Authors:  Samah Abo El Abass; Heba Elmansi
Journal:  R Soc Open Sci       Date:  2018-10-31       Impact factor: 2.963

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.